Altogen Biosystems Launches Nanoparticle-based In-Vivo Transfection Reagent

Altogen Biosystems has announced launch of Nanoparticle-based transfection reagent for use in laboratories and research facilities for animal testing. Transfection is one of the major laboratory methods used to introduce DNA and RNA molecules into cells and tissues. This technique makes it possible to cross the cellular barriers and deliver a gene or a small interfering RNA (siRNA) into the cells for research or therapeutic purposes.

The company has previously developed lipid- and polymer-based in vivo transfection reagents used for testing pharmaceuticals in animals. Altogen Biosystems recently developed novel nanoparticles biotechnology that allows efficient delivery of various biomolecules into animal tissues via systemic administration, as well as intraperitoneal and direct intratumoral injections.